Hyperprolactinemia: prevalence, diagnosis, cause and consequences

Authors

Keywords:

hyperprolactinemia: prevalence, diagnosis, cause and consequences.

Abstract

Hyperprolactinemia is a hormonal disorder related to the hypothalamus-pituitary axis, it is diagnosed by a high serum level of prolactin, in women from 20 to 25 ng/ml and in men, 17 ng/ml, this disorder can have various causes. The objective of this research work is to analyze the prevalence, diagnosis, causes and consequences of hyperprolactinemia. For this, a documentary-type descriptive methodology was designed, where a bibliographic review was carried out, the results showed that the prevalence is established at less than 1% worldwide, although in certain specific populations a prevalence of 50% more or less is reached, the diagnosis was made by measuring prolactin levels, in addition to other resources such as liquid chromatography or magnetic resonance imaging, this disorder can be caused by various factors, such as the use of antipsychotics, motherhood and lactation, or the presence of other diseases such as kidney failure. As for the consequences, there may be hormonal alterations such as delayed puberty, amenorrhea, galactorrhea, and in men sexual dysfunction and various other consequences that compromise the health status of the person suffering from this disorder can manifest, so the measurement of levels Thyrotropin and prolactin levels are excellent biomarkers for the diagnosis of hyperprolactinemia except in clinical conditions such as antipsychotic induction or chronic renal failure, and analysis by liquid chromatography or magnetic resonance imaging can improve this process.

Downloads

Download data is not yet available.

References

Alosaimi, F. D., Fallata, E. O., Abalhassan, M., Alhabbad, A., Alzain, N., Alhaddad, B., & Alassiry, M. Z. (2018). Prevalence and risk factors of hyperprolactinemia among patients with various psychiatric diagnoses and medications. International Journal of Psychiatry in Clinical Practice, 22(4), 274-281. Retrieved from https://www.tandfonline.com/doi/pdf/10.1080/13651501.2018.1425459?needAccess=true&role=button

AMARO, C. D. N. (2019). Análisis del efecto de la hiperprolactinemia inducida por levosulpirida sobre los niveles de prolactina en el vítreo de pacientes con retinopatía diabética. Retrieved from http://ri-ng.uaq.mx/xmlui/bitstream/handle/123456789/1215/RI005082.pdf?sequence=1&isAllowed=y

Aranha, A. F. (2022). Hiperprolactinemia e cânceres ginecológicos: revisão sistemática e meta-análise. Universidade de São Paulo, Retrieved from https://www.teses.usp.br/teses/disponiveis/5/5139/tde-09062022-114337/publico/AlineFernandaAranhaVersaoCorrigida.pdf

Ardito, L., D'Adda, D., & Petruzzelli, A. M. (2018). Mapping innovation dynamics in the Internet of Things domain: Evidence from patent analysis. Technological Forecasting and Social Change, 136, 317-330. Retrieved from https://www.sciencedirect.com/science/article/pii/S0040162517305498

Carranza-Lira, S., Daza-Carrasco, M. L., & Chán-Verdugo, R. (2017). Frecuencia de tirotropina elevada en mujeres con hiperprolactinemia. Revista Médica del Instituto Mexicano del Seguro Social, 55(1), 53-57. Retrieved from https://www.redalyc.org/journal/4577/457749926008/457749926008.pdf

Chacín, M., Valero, P., Prieto, C., Añez, R. J., Rojas, J., Lubo, A., . . . Fonseca, E. (2012). Valores de referencia de las hormonas tiroideas y TSH en individuos adultos de Maracaibo, Venezuela. Revista Latinoamericana de Hipertensión, 7(4), 88-95. Retrieved from https://www.redalyc.org/pdf/1702/170230886004.pdf

Delcour, C., Robin, G., Young, J., & Dewailly, D. (2019). PCOS and Hyperprolactinemia: what do we know in 2019? Clinical Medicine Insights: Reproductive Health, 13, 1179558119871921. Retrieved from https://journals.sagepub.com/doi/pdf/10.1177/1179558119871921

di Filippo, L., Doga, M., Resmini, E., & Giustina, A. (2020). Hyperprolactinemia and bone. Pituitary, 23(3), 314-321. Retrieved from https://link.springer.com/article/10.1007/s11102-020-01041-3

Díaz, R. E., Véliz, J., & Wohllk, N. (2015). Laboratorio de hormonas: aspectos prácticos. Revista Médica Clínica Las Condes, 26(6), 776-787. Retrieved from https://www.sciencedirect.com/science/article/pii/S0716864015001534

García Barriga, A. (2021). Estudio prospectivo y controlado sobre el riesgo de osteopenia, osteoporosis y fractura ósea en pacientes con hiperprolactinemia iatrogénica por antipsicóticos. Retrieved from https://gredos.usal.es/bitstream/handle/10366/147494/TFG_Garc%C3%ADaBarrigaA_OsteopeniaOsteoporosis.pdf?sequence=1

Ioachimescu, A. G., Fleseriu, M., Hoffman, A. R., Vaughan III, T. B., & Katznelson, L. (2019). Psychological effects of dopamine agonist treatment in patients with hyperprolactinemia and prolactin-secreting adenomas. European Journal of Endocrinology, 180(1), 31-40. Retrieved from https://scholar.archive.org/work/fd55wrqrb5dslaf4bcrigsb6jy/access/wayback/https://eje.bioscientifica.com/downloadpdf/journals/eje/180/1/EJE-18-0682.pdf

Jiménez, B., Liberman, C., Rojas, P., & Romero, C. (2005). La macroprolactina, diagnóstico diferencial de la hiperprolactinemia. Revista Hospital Clínico evista Hospital Clínico evista Hospital Clínico Universidad de Chile Vol, 16(3). Retrieved from https://redclinica.cl/Portals/0/Users/014/14/14/la%20macroproactina%203_2005.pdf

Levine, S., & Muneyyirci-Delale, O. (2018). Stress-induced hyperprolactinemia: pathophysiology and clinical approach. Obstetrics and gynecology international, 2018. Retrieved from https://www.hindawi.com/journals/OGI/2018/9253083/

Lizaso, H. G., & García, Y. G. (2018). Características clínicas y manejo de la macroprolactinemia como causa de hiperprolactinemia. Revista Cubana de Obstetricia y Ginecología, 44(1), 1-11. Retrieved from https://www.medigraphic.com/pdfs/revcubobsgin/cog-2018/cog181p.pdf

Matalliotaki, C., Matalliotakis, M., Rahmioglu, N., Mavromatidis, G., Matalliotakis, I., Koumantakis, G., . . . Zervou, M. I. (2019). Role of FN1 and GREB1 gene polymorphisms in endometriosis. Molecular Medicine Reports, 20(1), 111-116. Retrieved from https://www.spandidos-publications.com/10.3892/mmr.2019.10247?text=fulltext

Mendoza, A. M., Cuartero, B. G., Oyakawa, Y., & Castellanos, R. B. (2016). Prolactinomas en la población pediátrica. Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría (AEP), 85(3), 158-159.

Montejo, Á. L., Arango, C., Bernardo, M., Carrasco, J. L., Crespo-Facorro, B., Cruz, J. J., . . . González-Pinto, A. (2016). Psiquiatría y Salud Mental.

Montenegro, I. M., & Alonso, C. B. (2020). Quiste de bolsa de Rathke e hiperprolactinemia, una causa infrecuente de amenorrea primaria. Endocrinología y Diabetes, 13(2), 61-63. Retrieved from http://revistasoched.cl/2_2020/V13-N-2-2020.pdf#page=26

Morales Bacas, E. (2018). Aplicación de un protocolo asistencial en una unidad de salud mental para la detección y manejo clínico de la hiperprolactinemia secundaria al uso de antipsicóticos. Retrieved from https://repositori.uji.es/xmlui/bitstream/handle/10234/176564/TFG_2018_MoralesBacasElena.pdf?sequence=1&isAllowed=y

Panta, P., & Cecilia, A. (2019). Determinación de Hiperprolactinemia en mujeres de 18 a 22 años que toman anticonceptivos en la carrera de Tecnología Médica junio-agosto 2015. Retrieved from http://repositorio.usanpedro.pe/bitstream/handle/USANPEDRO/12096/Tesis_61269.pdf?sequence=1&isAllowed=y

Parmley Jr, L. F., Senior, M. R. M., McKenna, D. H., & Johnston, L. C. G. S. (1970). Clinically deceptive massive pulmonary embolism. Chest, 58(1), 15-23. Retrieved from https://www.sciencedirect.com/science/article/pii/S0012369215384592

Rubio-Guerra, A. F., Morales-López, H., Garro-Almendaro, A. K., Portillo-Muñoz, M. I., Durán-Salgado, M. B., & Lozano-Nuevo, J. J. (2017). Correlación entre las concentraciones de ácido úrico y disfunción vascular en adultos jóvenes. Medicina Interna de México, 32(6), 620-624. Retrieved from https://www.medigraphic.com/pdfs/medintmex/mim-2016/mim166d.pdf

Ruiz-Mejía, R., Ortega-Olivares, L. M., Naranjo-Carmona, C. A., & Suárez-Otero, R. (2017). Tratamiento de la hipercalemia en pacientes con enfermedad renal crónica en terapia dialítica. Medicina Interna de México, 33(6), 778-796. Retrieved from https://www.scielo.org.mx/pdf/mim/v33n6/0186-4866-mim-33-06-778.pdf

Sancho López, C. (2018). Cifras de normalidad de testosterona y rangos por década en el sector sanitario Zaragoza 2. Retrieved from http://repositorio.usj.es/bitstream/123456789/148/1/Cifras%20de%20normalidad.pdf

Sandoval González, G. (2016). Diagnóstico oportuno de macropolactina como una posible causa de hiperprolactinemia empleando el método de precipitación con polietilenglicol. Retrieved from https://repositorioinstitucional.buap.mx/bitstream/handle/20.500.12371/14498/606816TL.pdf?sequence=1

Sharma, L. K., Sharma, N., Gadpayle, A. K., & Dutta, D. (2016). Prevalence and predictors of hyperprolactinemia in subclinical hypothyroidism. European journal of internal medicine, 35, 106-110. Retrieved from https://www.sciencedirect.com/science/article/pii/S0953620516302199

Sirohi, T., & Singh, H. (2018). Estimation of serum prolactin levels and determination of prevalence of hyperprolactinemia in newly diagnosed cases of subclinical hypothyroidism. Journal of family medicine and primary care, 7(6), 1279. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293902/

Tewksbury, A., & Olander, A. (2016). Management of antipsychotic-induced hyperprolactinemia. Mental Health Clinician, 6(4), 185-190. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007722/

Vargas Quispe, P. A. G. (2017). Grado de Correlación entre el Estrés Académico y la Prolactina Sérica en las Estudiantes de la Escuela Profesional de Tecnología Médica que Cursan el Semestre Académico 2016-II de la Universidad Privada de Tacna-Perú, Año 2016. Retrieved from https://repositorio.upt.edu.pe/bitstream/handle/20.500.12969/189/Vargas-Quispe-Patricia.pdf?sequence=1

Vilar, L., Abucham, J., Albuquerque, J. L., Araujo, L. A., Azevedo, M. F., Boguszewski, C. L., . . . Duarte, F. H. (2018). Controversial issues in the management of hyperprolactinemia and prolactinomas–An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism. Archives of endocrinology and metabolism, 62, 236-263. Retrieved from https://www.scielo.br/j/aem/a/YYhNDhks3xZndj8xG99bM3F/?lang=en

Vilar, L., Vilar, C. F., Lyra, R., & da Conceicao Freitas, M. (2019). Pitfalls in the diagnostic evaluation of hyperprolactinemia. Neuroendocrinology, 109(1), 7-19. Retrieved from https://www.karger.com/Article/FullText/499694

Wong-Anuchit, C., Mills, A. C., Schneider, J. K., Rujkorakarn, D., Kerdpongbunchote, C., & Panyayong, B. (2016). Internalized stigma of mental illness scale-Thai version: translation and assessment of psychometric properties among psychiatric outpatients in central Thailand. Archives of Psychiatric Nursing, 30(4), 450-456. Retrieved from https://www.sciencedirect.com/science/article/pii/S0883941716000339

Woon, F. L., Sood, S., & Hedges, D. W. (2010). Hippocampal volume deficits associated with exposure to psychological trauma and posttraumatic stress disorder in adults: a meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 34(7), 1181-1188. Retrieved from http://thehubedu-production.s3.amazonaws.com/uploads/4991/a09d3113-87f1-4b40-87e6-b81eee5c06bf/Psych_PTSD_Article.pdf

Xia, M. Y., Lou, X. H., Lin, S. J., & Wu, Z. B. (2018). Optimal timing of dopamine agonist withdrawal in patients with hyperprolactinemia: a systematic review and meta-analysis. Endocrine, 59, 50-61. Retrieved from https://kd.nsfc.gov.cn/paperDownload/ZD20071980.pdf

Published

2023-01-27

How to Cite

Merchan Villafuerte, K. M. ., & Arteaga Cuadros, A. G. . (2023). Hyperprolactinemia: prevalence, diagnosis, cause and consequences . Revista Científica Arbitrada Multidisciplinaria PENTACIENCIAS - ISSN 2806-5794., 5(1), 457–472. Retrieved from https://editorialalema.org/index.php/pentaciencias/article/view/464

Issue

Section

Artículos de revisión